Drug Discovery Today is fully peer-reviewed and is published on a monthly basis in digital format. The magazine publishes reviews covering the whole of the preclinical drug discovery process, from target identification and validation to candidate selection. The reviews are at the cutting edge of the science underpinning drug discovery, and the translation of these sciences to therapies.
Keynote Address by Steve Dreamer, VP and Global Head of Operations, Novartis, at our Summit 2008 at the Evian Royal Resort, Lake Geneva, Switzerland.